Agilent Technologies, Inc. (A)
NYSE·Healthcare·Medical - Diagnostics & Research
$114.83
-0.66%
Mkt Cap $34.18B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $1.81B | $1.80B | -0.54% | $1.37 | $1.36 | -0.73% | — | — |
| Q4 2025 Nov 24, 2025 | $1.83B | $1.84B | +0.36% | $1.58 | $1.59 | +0.36% | — | — |
| Q3 2025 Aug 27, 2025 | $1.68B | $1.74B | +3.17% | $1.37 | $1.37 | +0.00% | — | — |
| Q2 2025 May 28, 2025 | $1.63B | $1.67B | +2.54% | $1.26 | $1.31 | +3.97% | — | — |
| Q1 2025 Feb 26, 2025 | $1.67B | $1.68B | +0.66% | $1.28 | $1.31 | +2.34% | — | — |
| Q4 2024 Nov 25, 2024 | $1.67B | $1.70B | +1.70% | $1.41 | $1.46 | +3.55% | — | — |
| Q3 2024 Aug 21, 2024 | $1.56B | $1.58B | +1.32% | $1.26 | $1.32 | +4.76% | — | — |
| Q2 2024 May 29, 2024 | $1.58B | $1.57B | -0.56% | $1.19 | $1.22 | +2.52% | — | — |
| Q1 2024 Feb 27, 2024 | $1.59B | $1.66B | +4.45% | $1.22 | $1.29 | +5.74% | — | — |
| Q4 2023 Nov 20, 2023 | $1.59B | $1.69B | +6.37% | $1.34 | $1.38 | +2.99% | — | — |
| Q3 2023 Aug 15, 2023 | $1.69B | $1.67B | -1.22% | $1.37 | $1.43 | +4.38% | — | — |
| Q2 2023 May 23, 2023 | $1.67B | $1.72B | +2.56% | $1.26 | $1.27 | +0.79% | — | — |
| Q1 2023 Feb 28, 2023 | $1.70B | $1.76B | +3.29% | $1.30 | $1.37 | +5.38% | — | — |
| Q4 2022 Nov 21, 2022 | $1.76B | $1.85B | +5.06% | $1.39 | $1.53 | +10.07% | — | — |
| Q3 2022 Aug 16, 2022 | $1.64B | $1.72B | +4.92% | $1.20 | $1.34 | +11.67% | — | — |
| Q2 2022 May 24, 2022 | $1.62B | $1.61B | -0.58% | $1.12 | $1.13 | +0.89% | — | — |
| Q1 2022 Feb 22, 2022 | $1.65B | $1.67B | +1.23% | $1.18 | $1.21 | +2.54% | — | — |
| Q4 2021 Nov 22, 2021 | $1.46B | $1.66B | +13.60% | $1.17 | $1.21 | +3.42% | — | — |
| Q3 2021 Aug 17, 2021 | $1.66B | $1.59B | -4.41% | $0.99 | $1.10 | +11.11% | — | — |
| Q2 2021 May 25, 2021 | $1.75B | $1.52B | -12.63% | $0.82 | $0.97 | +18.29% | — | — |